Citius Pharmaceuticals CTXR
$ 0.16
-4.65%
Quarterly report 2024-Q2
added 08-12-2024
Citius Pharmaceuticals Cash Flow 2011-2024 | CTXR
Annual Cash Flow Citius Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-29.1 M | -28.4 M | -24.3 M | -16.9 M | -12.4 M | -11.3 M | -7.97 M | -5.9 M | -2.39 M | -183 K | -1.1 M | -918 K | -20.8 K |
Depreciation & Amortization |
2.67 K | 2.92 K | 1.49 K | 844 | 893 | 1.75 K | 2.63 K | 1.34 K | - | - | - | - | - |
Accounts Payables |
2.93 M | 1.17 M | 1.28 M | 1.86 M | 2.71 M | 1.57 M | 602 K | 909 K | 559 K | 106 K | 11.5 K | - | 906 |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Citius Pharmaceuticals
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -6.14 M | - | - | - | -4.82 M | -22 M | - | - | -4.65 M | -18.7 M | -13.8 M | - | -9.56 M | -13.6 M | -9.58 M | -9.56 M | -5.11 M | -9.53 M | -6.01 M | -5.11 M | -2.16 M | -8.81 M | -6.57 M | -2.16 M | -2.44 M | -4.54 M | -2.14 M | -2.44 M | -1.31 M | - | -4.13 M | -1.31 M | -697 K | -1.68 M | -1.05 M | -697 K | -735 K | -603 K | -183 K | -735 K | -522 K | -13.2 K | -9.97 K | -17.5 K | -236 | -14.9 K | -8.9 K | -236 | -2.2 K | -15.8 K | -10.7 K | -2.2 K |
Depreciation & Amortization |
- | - | 578 | - | - | - | 730 | 2.19 K | - | - | 730 | 761 | 305 | - | 153 | 632 | 354 | 153 | 177 | 706 | 470 | 177 | 235 | 1.52 K | 1.28 K | 235 | 642 | 2.02 K | 1.34 K | 642 | 672 | - | 671 | 672 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
1.66 M | 2.67 M | 2.65 M | 2.93 M | 3.08 M | 2.73 M | 1.54 M | 1.17 M | 1.69 M | 1.71 M | 1.79 M | 1.28 M | 1.35 M | 1.28 M | 984 K | 1.86 M | 1.86 M | 1.86 M | 1.55 M | 2.71 M | 2.71 M | 2.71 M | 2.08 M | 1.57 M | 1.57 M | 1.57 M | 561 K | 602 K | 602 K | 602 K | 986 K | 909 K | 909 K | 909 K | 459 K | 559 K | 559 K | 559 K | 199 K | 106 K | 106 K | 106 K | 172 K | 11.5 K | 11.5 K | 198 | 600 | - | - | 906 | 906 | 906 | 906 | 906 |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency